Moderna’s mRNA-1083 Vaccine Shows Promise in Combating Flu and COVID-19
Moderna, the pharmaceutical company, has reported encouraging outcomes from its ongoing trial of a novel vaccine named mRNA-1083. This trial, targeting adults aged 50 and above, demonstrated that an experimental … Read More